News News Select Year All Years 2026 (17) 2025 (34) 2024 (29) 2023 (30) 2022 (33) 2021 (27) 2020 (34) 2019 (32) 2018 (42) 2017 (35) 2016 (43) 2015 (53) 2014 (26) 2013 (21) 2012 (16) 2011 (6) 2010 (4) 2009 (5) 2007 (1) 2006 (1) Search News Found 489 Results Page 39 of 49« First«...102030...3738394041...»Last » June 26, 2015 DBV Technologies Proudly Welcomes Dr. Hugh Sampson as Chief Scientific Officer June 23, 2015 DBV Technologies’ June 23, 2015 Combined Shareholders’ Meeting June 23, 2015 DBV Technologies Confirms Planned Initiation of Viaskin® Peanut Global Phase III Clinical Trial in Children Following Endof-Phase II Meeting with FDA and PIP approval by EMA June 10, 2015 Key Scientific Data Demonstrating that Epicutaneous Administration May Reactivate Protective Immunity against Pertussis in an experimental model published in Vaccine June 8, 2015 DBV Technologies Presents Clinical and Scientific Data at the EAACI Congress June 8, 2015 DBV Technologies Presents Clinical and Scientific Data at the EAACI Congress June 4, 2015 DBV Technologies Announces EMA Paediatric Committee (PDCO) positive opinion on the Paediatric Investigation Plan for Viaskin® Peanut for the Treatment of Peanut Allergic Children June 2, 2015 DBV Technologies to Attend Upcoming Investor Conferences June 2, 2015 Mixed General Assembly of June 23, 2015 Procedures for obtaining preparatory documents for the Assembly May 29, 2015 Monthly information regarding the total number of voting rights and total number of shares of the Company Page 39 of 49« First«...102030...3738394041...»Last »
